AzTrials
AzTrials

DysmenorrheaNCT07831421

Effects of Interferential Current and Kinesio Taping Added to Pelvic Floor Muscle Exercises in Women With Primary Dysmenorrhea

A study testing pelvic floor muscle training, Interferential current and Kinesio taping in people with Dysmenorrhea, run by Istanbul Medipol University Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary dysmenorrhea can adversely affect pain, sleep, and health-related quality of life in young women. This study will investigate and compare the effects of interferential current (IFC) and Kinesio taping (KT) added to pelvic floor muscle exercise (PFME) in women with primary dysmenorrhea. Read more about this study

Who is it for?
Ages 18 to 30 years, women only
Conditions the study is for
Dysmenorrhea
What is being tested?
pelvic floor muscle training, Interferential current and Kinesio taping
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Jan 2026to 12 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • The inclusion criteria were being 18-30 years of age, having regular menstrual cycles, having a diagnosis of primary dysmenorrhea, reporting menstrual pain greater than 4/10 on the Visual Analog Scale (VAS) during the previous 6 months

Who cannot join

  • conditions associated with secondary dysmenorrhea, such as endometriosis, adenomyosis, uterine fibroids, or endometrial polyps; a history of pelvic infection; use of an intrauterine device or oral contraceptives; previous pregnancy or childbirth; presence of a cardiac pacemaker; pelvic floor dysfunction related to a neurological disorder; and inability to provide informed consent

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul

    Istanbul, 34000

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Interferential Current and Kinesio Taping Added to Pelvic Floor Muscle Exercises in Women With Primary Dysmenorrhea: A Three-Arm Randomized Controlled Trial

Primary dysmenorrhea can adversely affect pain, sleep, and health-related quality of life in young women. This study will investigate and compare the effects of interferential current (IFC) and Kinesio taping (KT) added to pelvic floor muscle exercise (PFME) in women with primary dysmenorrhea. The study will be designed as a three-arm randomized controlled trial. A total of 60 women aged 18-30 years will be recruited and randomly allocated to one of three groups: PFME+IFC, PFME+IFC+KT, or PFME alone. Pain will be assessed using the Short-Form McGill Pain Questionnaire and a pain body diagram, sleep quality will be evaluated using the subjective sleep quality component of the Pittsburgh Sleep Quality Index, and health-related quality of life will be assessed using the SF-36.

Conditions
Dysmenorrhea
Being tested
pelvic floor muscle training, Interferential current, Kinesio taping
Keywords
primary dysmenorrhea, pelvic floor muscle exercise, interferential current, Kinesio taping, pain
Medical subject headings
Dysmenorrhea, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pelvic floor muscle trainingOther

    All participants received training to improve awareness and correct activation of the pelvic floor muscles before beginning the exercise program. One set consisted of 10 rapid and 10 slow pelvic floor muscle contractions. During rapid contractions, participants were instructed to contract and relax the pelvic floor muscles quickly. During slow contractions, they were instructed to gradually increase the contraction, maintain it for 10 seconds, and then slowly relax the muscles.

    The pelvic floor muscle exercise (PFME) program was performed 3 days per week, with 3 sessions per day. Over the 8-week intervention period, the number of sets performed during each session was progressively increased from 1 to 10. Exercise positions were also progressively varied and included supine lying, child's pose, sitting, standing, squatting, and bridging. Participants recorded their exercises in exercise diaries, which were reviewed weekly to monitor adherence

  • Interferential currentOther

    Interferential current (IFC) was applied on the first day of the second menstrual cycle to participants allocated to the PFME+IFC and PFME+IFC+KT groups. IFC was administered to the lumbar region using a quadripolar technique with four vacuum or plate electrodes. Each application lasted 20 minutes, with the stimulation frequency set at 90-100 Hz. Treatment was delivered using a Chattanooga Intelect Advanced device. The intervention was performed under standardized conditions to ensure participant comfort.

  • Kinesio tapingOther

    Kinesio taping (KT) was applied only to participants in the PFME+IFC+KT group. The application was performed on the first day of the second menstrual cycle, with the taping sites individualized according to the pain locations identified on each participant's pain body diagram.

    An I-strip was applied to the suprapubic region using the ligament technique at 100% tension. A star-shaped taping technique was applied over the sacral region. For areas of fascial sensitivity, a Y-strip was applied using a fascial correction technique with 25-50% tension, whereas small I-strips were applied over localized tender points using the space correction technique with 25-50% tension. The tape was planned to be replaced every 3 days, with a 1-day tape-free interval before the second application

Study groups in NCT07831421
Study groupRoleWhat they receive
PFMT and ınterferential currentExperimentalNot described
Receives: Other: pelvic floor muscle training; Other: Interferential current
PFMT and ınterferential current and kinesiotapingExperimentalNot described
Receives: Other: pelvic floor muscle training; Other: Interferential current; Other: Kinesio taping
PFMTActive comparatorNot described
Receives: Other: pelvic floor muscle training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Short-Form McGill Pain Questionnaire

    Pain characteristics were assessed using the Short-Form McGill Pain Questionnaire (SF-MPQ). The questionnaire consists of 15 pain descriptors, including 11 sensory and 4 affective items. Each descriptor is scored from 0 (none) to 3 (severe), with higher total scores indicating greater pain severity. The validity and reliability of the Turkish version have been established

    Measured: First day of the first menstrual cycle, first day of the second menstrual cycle, and first day of the third menstrual cycle

  2. pain body diagram

    The distribution of pain was assessed using a standardized body diagram on which participants marked the anatomical regions in which they experienced pain. For the present study, the total pain body diagram score was calculated as the total number of regions marked as painful.

    Measured: First day of the first menstrual cycle, first day of the second menstrual cycle, and first day of the third menstrual cycle

  3. Pittsburgh Sleep Quality Index

    Subjective sleep quality was assessed using the subjective sleep quality component of the Pittsburgh Sleep Quality Index (PSQI). The PSQI comprises seven components assessing different aspects of sleep, with higher scores indicating poorer sleep quality. The validity and reliability of the Turkish version have previously been established (Ağargün et al., 1996). In the present study, only the subjective sleep quality component was included in the analysis.

    Measured: First day of the first menstrual cycle, first day of the second menstrual cycle, and first day of the third menstrual cycle

  4. SF-36

    Health-related quality of life was assessed using the SF-36 Health Survey. The instrument assesses eight health domains: physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, bodily pain, and general health. The health change item was also evaluated. Domain scores range from 0 to 100, with higher scores indicating better perceived health status. The validity and reliability of the Turkish version have been established

    Measured: First day of the first menstrual cycle, first day of the second menstrual cycle, and first day of the third menstrual cycle

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2026
  2. Study start10 Jan 2026
  3. Primary completion22 Mar 2026
  4. Study completion12 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07831421
Sponsor's protocol ID
E-10840098-202.3.02-2921
Status last verified
Sep 2026
First submitted
10 Sep 2026
Last updated
21 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing pelvic floor muscle training, Interferential current and Kinesio taping in people with Dysmenorrhea, run by Istanbul Medipol University Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Short-Form McGill Pain Questionnaire (time frame: First day of the first menstrual cycle, first day of the second menstrual cycle, and first day of the third menstrual cycle). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in